MIT Expert on the Progress of mRNA Vaccines
Following the successful development of COVID-19 vaccines, researchers hope to deploy mRNA-based therapies to combat many other diseases. Two mRNA vaccines, which were granted emergency…
Vaccine News
mRNA COVID-19 Vaccines – Like Pfizer and Moderna – Work Better Against Variants of Concern
A comparison of four COVID-19 vaccinations shows that messenger RNA (mRNA) vaccines — Pfizer-BioNTech and Moderna — perform better against the World Health Organization (WHO)’s…
National Institutes of Health Launches Clinical Trial of Epstein-Barr Virus Vaccine
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an early-stage clinical trial to evaluate…
COVID-19 Vaccines May Be Significantly Less Effective in People With Severe Obesity
Study suggests severe obesity blunts antibody response to COVID-19 vaccines. Pfizer/BioNTech linked to a more robust antibody response than CoronaVac in people with severe obesity….
Why the 100-Year-Old BCG Tuberculosis Vaccine Is So Broadly Protective Against Infections in Newborns
Researchers discover changes in metabolite and lipid profiles, providing clues for designing future vaccines for newborns. The century-old Bacille Calmette-Guérin (BCG) vaccine against tuberculosis is…
COVID-19 mRNA Vaccine Technique Shows Promise for Treating Heart Disease
A technique for delivering genetic material to the body is being investigated as a means of repairing damaged heart muscle after a heart attack. The…
Mix-and-Match Approach to Booster Vaccination Offers the Best Protection Against COVID-19
A new study on Chile’s national COVID-19 vaccination program, being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022, Lisbon,…
COVID-19 Third Dose Vaccine Protection Against Hospitalization Wanes After 3 Months
Kaiser Permanente finds the Pfizer COVID-19 third dose vaccine protection against hospitalization from omicron wanes after 3 months. A research study released on April 22,…
Longer Interval Between COVID-19 Vaccines Generates Up to 9x As Many Protective Antibodies
New research has shown that a longer interval between primary COVID-19 vaccine doses can boost antibody production up to nine-fold. The study will be presented…
Fully Vaccinated and Boosted Woman Catches COVID Omicron Infection Just 20 Days After Delta
A fully vaccinated and boosted 31-year-old woman tested positive for Omicron strain of SARS-CoV-2 just 20 days after having Delta infection. Researchers in Spain provide…
COVID-19 Infection Granted Unvaccinated People Strong, Long-Lasting Protection on Par With mRNA Vaccines
Researchers looked at COVID-19 immunity prior to emergence of the omicron variant to help inform vaccine and infection control policy. A study released in JAMA…
Newly Developed COVID Vaccine Could Protect Against Omicron and Other Variants
Vaccine developed at MedUni Vienna delivers promising data. The preclinical data for a vaccine developed at MedUni Vienna to protect against SARS-CoV-2 indicates that it…
COVID-19 Vaccine-Associated Breakthrough Bleeding Reported in Non-Menstruating People
Study draws attention to potential physical and mental side effects of vaccination in people with diverse gender identities. Many people who do not usually menstruate…
Scientists Have Now Analyzed Ultrasounds for Birth Defects Associated With COVID-19 Vaccines
COVID-19 Vaccine Not Associated With Birth Defects Detectable on Ultrasound Findings fill gap left vacant when pregnant people were excluded from the initial trials. Scientists…
NIH Begins Clinical Trial Evaluating 2nd COVID-19 Vaccine Booster Shots in Adults
Study Includes Multiple Variant Vaccines Adults interested in joining this study should visit ClinicalTrials.gov and search identifier NCT05289037 for a list of sites and contacts….
Revolutionary DNA Nanotechnology Speeds Up Development of Vaccines by More Than One Million Times
Revolutionary tool will meet future pandemics with accelerated response. A new tool speeds up development of vaccines and other pharmaceutical products by more than one…
NIH Launches Clinical Trial of Three mRNA HIV Vaccines
Phase 1 Study Is Among First to Examine mRNA Technology for HIV. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National…
Inexpensive New COVID-19 Vaccine Could Be Accessible for More of the World
The protein subunit vaccine, which can be manufactured using engineered yeast, has shown promise in preclinical studies. While many people in wealthier countries have been…
